Acute Prostatitis
Common pathogens:
E. coli (most common)
Pseudomonas
Klebsiella
Enterococcus
Investigations Acute Prostatitis
Urine dipstick and midstream sample for MCS
If acutely unwell: FBC, CRP, blood cultures
Management Acute Prostatitis
Admit if severely unwell/septic/abscess etc.
Consider urgent referral if immunocompromised/diabetic/urological condition
Antibiotics (14-day course):
1st line: Ciprofloxacin 500 mg BD
Alternative: Ofloxacin 200 mg BD
If contraindicated: Trimethoprim 200 mg BD
Man with fever, dysuria, perineal pain, tender boggy prostate on DRE
1st line treatment
Ciprofloxacin 500 mg BD for 14 days
(BPH) Investigations
PSA (can be mildly raised in BPH)
IPSS score:
0–7: mild
8–19: moderate
20–35: severe
Imaging (e.g. MRI) if diagnostic uncertainty or haematuria
IPSS score:
(BPH)
0–7: mild
8–19: moderate
20–35: severe
Management (BPH)
Voiding symptoms → 1st line: alpha-blocker (tamsulosin, alfuzosin)
Persistent symptoms despite alpha-blocker → Consider anticholinergic (e.g. oxybutynin)
Enlarged prostate → 1st line: 5-alpha-reductase inhibitor (finasteride, dutasteride)
Inhibit conversion of testosterone to DHT - reduces prostate volume
Surgical: TURP if refractory to medical therapy
Enlarged prostate →
NICE defines ‘enlarged’ referencing - estimated prostate > 30g / PSA > 1.4ng/ml
Most common cancer in men
Prostate Cancer
most common subtype Prostate Cancer
Acinar adenocarcinoma = most common subtype (peripheral zone)
Risk Factors Prostate Cancer
age, African-Caribbean ethnicity, FHx
Erectile dysfunction - always check
Psa
Investigations Prostate Cancer
PSA
1st line imaging: MRI prostate
Biopsy: TRUS or transperineal
Staging: CT TAP ± PET
Age (years) PSA Threshold (ng/mL)
< 40 Use clinical judgement
40–49 > 2.5
50–59 > 3.5
60–69 > 4.5
70–79 > 6.5
> 79 > 20, or > 7.5 with symptoms of metastatic disease (e.g. bone pain, fatigue, weight loss)
Management
Local disease
Prostate Cancer
Low-risk: active surveillance (PSA, MRI, biopsy)
Intermediate/high-risk:
Radical prostatectomy
Radiotherapy ± brachytherapy
SEs: ED, incontinence
Metastatic disease mx
Prostate Cancer
Androgen deprivation therapy (ADT)
Bicalutamide (anti-androgen)
Goserelin (GnRH analogue)
Chemotherapy if hormone refractory
Smooth prostate + LUTS + mild PSA rise →
Bph
Nodular prostate + LUTS + PSA significantly raised →
cancer until proven otherwise
Back pain + LUTS + high PSA
Mets
Most common causes: Epididymo-orchitis
<35 years: STI (Chlamydia trachomatis, Neisseria gonorrhoeae)
Ceftriaxone + Doxycycline
>35 years: UTI pathogens (E. coli, Proteus, Klebsiella)
Ofloxacin or levofloxacin
sudden pain, N&V, absent cremasteric reflex
Must exclude torsion:
Investigations Epididymo-orchitis
First-pass urine NAAT for CT/NG
Urine dipstick ± MSU for culture
Consider STI screen and sexual health referral in <35 or at-risk
Management Likely STI-related (age <35 or STI risk factors)
Epididymo-orchitis
Ceftriaxone 1g IM stat
Plus Doxycycline 100mg BD for 14 days
ManagementEpididymo-orchitis
Likely UTI/enteric cause (age >35 or recent catheter)
Ofloxacin 200mg BD for 14 days
or
Levofloxacin 500mg OD for 10 days